Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,109 | -2,424 | -1,758 | -1,017 | -4,112 |
| Other Working Capital | 166 | 241 | 251 | 42 | -150 |
| Other Operating Activity | 252 | 207 | 121 | 49 | 138 |
| Operating Cash Flow | $-2,691 | $-1,976 | $-1,385 | $-926 | $-4,125 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,700 | 4,700 | 4,700 | 348 | 4,424 |
| Financing Cash Flow | $4,700 | $4,700 | $4,700 | $348 | $4,424 |
| Beginning Cash Position | 3,325 | 3,325 | 3,325 | 3,325 | 3,027 |
| End Cash Position | 5,334 | 6,049 | 6,641 | 2,747 | 3,325 |
| Net Cash Flow | $2,009 | $2,724 | $3,315 | $-579 | $299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,691 | -1,976 | -1,385 | -926 | -4,125 |
| Free Cash Flow | -2,691 | -1,976 | -1,385 | -926 | -4,125 |